Cover Image
市場調查報告書

Vivaldi Biosciences Inc.:產品平台分析

Vivaldi Biosciences Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 305686
出版日期 內容資訊 英文 20 Pages
訂單完成後即時交付
價格
Back to Top
Vivaldi Biosciences Inc.:產品平台分析 Vivaldi Biosciences Inc. - Product Pipeline Review - 2015
出版日期: 2015年08月26日 內容資訊: 英文 20 Pages
簡介

Vivaldi Biosciences Inc.是開發一般季節性流感及新型 (泛發型) 流感的預防疫苗之生物科技企業。

本報告提供Vivaldi Biosciences Inc.的醫藥品開發平台現狀及各開發階段比較分析,提供您藥物簡介,給藥途徑,各分子類型的藥物評估,暫停中的開發計劃等資訊。

Vivaldi Biosciences Inc.的基本資料

  • 概要
  • 主要資訊
  • 企業資料

Vivaldi Biosciences Inc.:R&D概要

  • 主要的治療範圍

Vivaldi Biosciences Inc.:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Vivaldi Biosciences Inc.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第Ⅰ階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式

Vivaldi Biosciences Inc.:藥物簡介

  • GHB-16L2 Vaccine
  • 禽流感A (H7N9) 疫苗
  • VB126 LAIV

Vivaldi Biosciences Inc.:開發平台分析

  • 各給藥途徑
  • 各分子類型

Vivaldi Biosciences Inc.:最近的開發平台趨勢

Vivaldi Biosciences Inc.:暫停中的計劃

Vivaldi Biosciences Inc.:總公司和子公司的所在地

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07448CDB

Summary

Global Markets Direct's, 'Vivaldi Biosciences Inc. - Product Pipeline Review - 2015', provides an overview of the Vivaldi Biosciences Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Vivaldi Biosciences Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Vivaldi Biosciences Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Vivaldi Biosciences Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Vivaldi Biosciences Inc.'s pipeline products

Reasons to buy

  • Evaluate Vivaldi Biosciences Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Vivaldi Biosciences Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Vivaldi Biosciences Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Vivaldi Biosciences Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Vivaldi Biosciences Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Vivaldi Biosciences Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Vivaldi Biosciences Inc. Snapshot
    • Vivaldi Biosciences Inc. Overview
    • Key Information
    • Key Facts
  • Vivaldi Biosciences Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Vivaldi Biosciences Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Vivaldi Biosciences Inc. - Pipeline Products Glance
    • Vivaldi Biosciences Inc. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Vivaldi Biosciences Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
  • Vivaldi Biosciences Inc. - Drug Profiles
    • GHB-16L2 Vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • influenza [strain A/H7N9] vaccine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • VB126 LAIV
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Vivaldi Biosciences Inc. - Pipeline Analysis
    • Vivaldi Biosciences Inc. - Pipeline Products by Route of Administration
    • Vivaldi Biosciences Inc. - Pipeline Products by Molecule Type
  • Vivaldi Biosciences Inc. - Recent Pipeline Updates
  • Vivaldi Biosciences Inc. - Dormant Projects
  • Vivaldi Biosciences Inc. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Vivaldi Biosciences Inc., Key Information
  • Vivaldi Biosciences Inc., Key Facts
  • Vivaldi Biosciences Inc. - Pipeline by Indication, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Stage of Development, 2015
  • Vivaldi Biosciences Inc. - Monotherapy Products in Pipeline, 2015
  • Vivaldi Biosciences Inc. - Phase I, 2015
  • Vivaldi Biosciences Inc. - Preclinical, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Route of Administration, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Molecule Type, 2015
  • Vivaldi Biosciences Inc. - Recent Pipeline Updates, 2015
  • Vivaldi Biosciences Inc. - Dormant Developmental Projects,2015

List of Figures

  • Vivaldi Biosciences Inc. - Pipeline by Top 10 Indication, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Stage of Development, 2015
  • Vivaldi Biosciences Inc. - Monotherapy Products in Pipeline, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Vivaldi Biosciences Inc. - Pipeline by Top 10 Molecule Type, 2015
Back to Top